231 related articles for article (PubMed ID: 8816430)
1. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3).
Memar O; Christensen B; Rajaraman S; Goldblum R; Tyring SK; Brysk MM; McCormick DJ; el-Zaim H; Fan JL; Prabhakar BS
J Immunol; 1996 Oct; 157(7):3171-7. PubMed ID: 8816430
[TBL] [Abstract][Full Text] [Related]
2. BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3.
Fan JL; Memar O; McCormick DJ; Prabhakar BS
J Immunol; 1999 Dec; 163(11):6228-35. PubMed ID: 10570315
[TBL] [Abstract][Full Text] [Related]
3. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.
Amagai M; Hashimoto T; Shimizu N; Nishikawa T
J Clin Invest; 1994 Jul; 94(1):59-67. PubMed ID: 8040292
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic.
Amagai M; Karpati S; Prussick R; Klaus-Kovtun V; Stanley JR
J Clin Invest; 1992 Sep; 90(3):919-26. PubMed ID: 1522242
[TBL] [Abstract][Full Text] [Related]
5. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
6. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.
Dworschak J; Recke A; Freitag M; Ludwig RJ; Langenhan J; Kreuzer OJ; Zillikens D; Schmidt E
J Dermatol Sci; 2012 Feb; 65(2):102-9. PubMed ID: 22261006
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and protein expression of EC1-2 and EC3-4 epitopes of pemphigus vulgaris antigen.
Zheng J; Kang X; Li W; Cheng Y; Tang M; Zhou W
Chin Med J (Engl); 2000 Nov; 113(11):1011-4. PubMed ID: 11776114
[TBL] [Abstract][Full Text] [Related]
9. Establishment of the mouse model by rabbit antiserum specific to EC1-2 or EC3-4 epitopes for studying the pathogenesis of pemphigus vulgaris.
Pan M; Zhao X; Xue F; Li W; Zheng J
Immunol Invest; 2006; 35(1):47-61. PubMed ID: 16531329
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
11. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
12. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome.
Nagasaka T; Nishifuji K; Ota T; Whittock NV; Amagai M
J Clin Invest; 2004 Nov; 114(10):1484-92. PubMed ID: 15545999
[TBL] [Abstract][Full Text] [Related]
13. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
[TBL] [Abstract][Full Text] [Related]
15. Detection of autoantibodies against bullous pemphigoid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins.
Ide A; Hashimoto T; Amagai M; Tanaka M; Nishikawa T
Exp Dermatol; 1995 Apr; 4(2):112-6. PubMed ID: 7543794
[TBL] [Abstract][Full Text] [Related]
16. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
[TBL] [Abstract][Full Text] [Related]
17. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
[TBL] [Abstract][Full Text] [Related]
18. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
[TBL] [Abstract][Full Text] [Related]
20. Role of intramolecular epitope spreading in pemphigus vulgaris.
Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
